Crossmark

Study Design of the Graft Patency After FFR-Guided Versus Angiography-Guided CABG Trial (GRAFFITI)

Crossref DOI link: https://doi.org/10.1007/s12265-018-9818-9

Published Online: 2018-07-19

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Toth, Gabor G.

De Bruyne, Bernard

Kala, Petr

Ribichini, Flavio L.

Casselman, Filip

Ramos, Ruben

Piroth, Zsolt

Fournier, Stephane

Van Mieghem, Carlos

Penicka, Martin

Mates, Martin

Van Praet, Frank

Degriek, Ivan

Barbato, Emanuele
License Information

Text and Data Mining valid from 2018-07-19
More Information

Article History

Received: 14 April 2018

Accepted: 2 July 2018

First Online: 19 July 2018

Compliance with Ethical Standards

: This study is aligned with the Helsinki Declaration’s principles, meaning all patients signed a written informed consent stating that participation was voluntary and that participation could be withdrawn at any time without any negative consequences concerning their current or future medical treatment. Study approval was obtained from the local ethical committees of each participating centers.

: Drs. Barbato and De Bruyne report research grants and consulting fees to the Cardiovascular Research Institute Aalst (Belgium) on their behalf from Abbott Vascular (St. Jude Medical). Dr. G Toth reports research grants and consulting fees from Abbott Vascular (St. Jude Medical), Medtronic, Boston Scientific and Biotronik. No other potential conflict of interest relevant to this original research was reported.